India Considers Sponsoring Rare Drugs Through First Two Trial Phases
This article was originally published in PharmAsia News
Executive Summary
An arm of India's government proposes public funding of early-stage clinical trials if they are conducted at 11 national institutes. The Department of Pharmaceuticals proposes the National Institutes of Pharmaceutical Education and Research receive the funding to focus on developing new drugs for neglected diseases. Under the plan, the government would assist Phase I and Phase II trials to help spur a part of the drug-development process that has the most risk. After surviving the first two trial phases, NIPERS would hand the drug or treatment to private industry to develop further in Phase III trials. (Click here for more